Scandinavian Medical Solutions AS (SMSMED) — Strategic Asset Allocation Index

Latest as of September 2022: 21.1%

Scandinavian Medical Solutions AS (SMSMED) has a Strategic Asset Allocation Index of 21.1% as of September 2022. Strategic assets (PP&E of Dkr13.15 Million plus long-term investments of Dkr-) total Dkr13.15 Million, measured against net assets of Dkr62.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

21.1%
Strategic Assets / Net Assets

Strategic Assets

Dkr13.15 Million
PP&E + LT Investments

PP&E

Dkr13.15 Million
DKK

Net Assets

Dkr62.19 Million
DKK

Scandinavian Medical Solutions AS Strategic Asset Allocation Index (2020–2022)

This chart shows how Scandinavian Medical Solutions AS's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2022. As of September 2022, the index stands at 21.1%, representing strategic assets of Dkr13.15 Million against net assets of Dkr62.19 Million DKK. Explore Scandinavian Medical Solutions AS cash conversion from operations to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Scandinavian Medical Solutions AS (2020–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Scandinavian Medical Solutions AS from 2020 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SMSMED stock market capitalisation.

Year SAAI Strategic Assets (DKK) PP&E LT Investments Net Assets Change (pp)
2022 21.1% Dkr13.15 Million Dkr13.15 Million Dkr- Dkr62.19 Million ▲ +20.6 pp
2020 0.5% Dkr24.16K Dkr24.16K Dkr- Dkr4.88 Million
pp = percentage points